Report error Found 42 Enz. Inhib. hit(s) with all data for entry = 50009671
Affinity DataEC50: 2nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 2nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 2nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 2nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 3nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
3D Structure (crystal)
Affinity DataEC50: 3nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 3nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 3nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 3nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 3nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 5nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 5nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 5nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 5nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 10nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 10nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 10nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 10nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 10nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 10nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 11nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 11nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 14nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 14nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 15nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 15nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 15nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 15nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 18nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 18nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 22nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 22nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 28nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 28nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 46nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 46nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: >1.00E+3nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: >1.00E+3nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: >1.00E+3nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: >1.00E+3nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: >1.00E+3nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
Affinity DataEC50: >1.00E+3nMAssay Description:Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysisMore data for this Ligand-Target Pair
